Wells Fargo’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$415K Buy
20,300
+3,953
+24% +$80.7K ﹤0.01% 3912
2025
Q1
$327K Buy
16,347
+972
+6% +$19.5K ﹤0.01% 3941
2024
Q4
$410K Buy
15,375
+3,460
+29% +$92.2K ﹤0.01% 3857
2024
Q3
$340K Buy
11,915
+408
+4% +$11.6K ﹤0.01% 3864
2024
Q2
$251K Buy
11,507
+2,081
+22% +$45.3K ﹤0.01% 4009
2024
Q1
$209K Buy
9,426
+1,479
+19% +$32.8K ﹤0.01% 4084
2023
Q4
$171K Buy
7,947
+1,546
+24% +$33.4K ﹤0.01% 4171
2023
Q3
$108K Sell
6,401
-5,011
-44% -$84.6K ﹤0.01% 4400
2023
Q2
$157K Buy
11,412
+5,578
+96% +$76.5K ﹤0.01% 4480
2023
Q1
$133K Sell
5,834
-18,247
-76% -$415K ﹤0.01% 4400
2022
Q4
$567K Buy
24,081
+19,979
+487% +$470K ﹤0.01% 3350
2022
Q3
$107K Buy
4,102
+838
+26% +$21.9K ﹤0.01% 4275
2022
Q2
$71K Sell
3,264
-101,099
-97% -$2.2M ﹤0.01% 4581
2022
Q1
$4.68M Sell
104,363
-3,359
-3% -$151K ﹤0.01% 2369
2021
Q4
$4.62M Sell
107,722
-462,813
-81% -$19.8M ﹤0.01% 2504
2021
Q3
$37.9M Buy
570,535
+62,997
+12% +$4.19M 0.01% 1200
2021
Q2
$37.2M Sell
507,538
-6,353
-1% -$466K 0.01% 1227
2021
Q1
$35.2M Sell
513,891
-77,215
-13% -$5.29M 0.01% 1222
2020
Q4
$39.7M Sell
591,106
-12,425
-2% -$834K 0.01% 1111
2020
Q3
$31.1M Buy
603,531
+46,058
+8% +$2.37M 0.01% 1126
2020
Q2
$21M Buy
557,473
+296,960
+114% +$11.2M 0.01% 1335
2020
Q1
$7.77M Buy
260,513
+254,404
+4,164% +$7.58M ﹤0.01% 1845
2019
Q4
$210K Buy
6,109
+2,510
+70% +$86.3K ﹤0.01% 4770
2019
Q3
$65K Buy
+3,599
New +$65K ﹤0.01% 5211